Tetsuya Ishikawa,
Makoto Mutoh,
Yuji Fuda,
Hiroshi Sakamoto,
Hisayuki Okada,
Michiaki Higashitani,
Yousuke Nakano,
Junichi Yamaguchi,
Kenji Enta, Takahiro Satoh,
Kamon Imai,
Toshinobu Horie,
Seibu Mochizuki
[show abstract]
[hide abstract]
ABSTRACT: The incidence of subacute stent thrombosis (SAT) within 30 days after stenting with a sirolimus-eluting stent (Cypher) for acute myocardial infarction (AMI) was retrospectively compared to that with bare-metal stents (BMS).
Among 559 lesions in 558 consecutive AMI from April 2003 to February 2006, the incidence of documented SAT after Cypher implantation (2/276 lesions, 0.72%) was almost the same as for BMS (2 cases, 0.71%). Aspirin (81-100 mg/day) plus ticlopidine (200 mg/day) were administered continuously after admission in all 4 cases.
Documented SAT did not increase after stenting with Cypher for AMI under aspirin plus ticlopidine.
Circulation Journal 09/2006; 70(8):1091-2. · 3.77 Impact Factor
